LMR Partners’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-66,251
Closed -$578K 1093
2023
Q1
$578K Buy
66,251
+25,747
+64% +$225K 0.01% 668
2022
Q4
$254K Buy
40,504
+10,144
+33% +$63.6K ﹤0.01% 960
2022
Q3
$106K Hold
30,360
﹤0.01% 1034
2022
Q2
$90K Buy
+30,360
New +$90K ﹤0.01% 1102
2020
Q1
Sell
-890,894
Closed -$1.75K 466
2019
Q4
$1.75K Buy
+890,894
New +$1.75K ﹤0.01% 144